We discuss the market size, growth drivers, and global competition facing China’s biopharma industry and suggest potential investment paths.
We discuss the market size, growth drivers, and global competition facing China’s biopharma industry and suggest potential investment paths.
By Chris Devonshire-Ellis Kyiv owes Beijing money for stalled BRI projects and will need to offer more than requests for financial assistance and tours of
Further extensions to China’s preferential tax policies will help support small and low-profit companies and key industries. Further extensions to China’s preferential tax policies will
China is a highly promising market for the global healthcare industry, yet it’s highly competitive and regulated. Download our latest China Briefing magazine where we
SinoSciences Group is a 1st distribution corporate for cutting-edge medical technologies within East Asia